Search results
David Duchovny admits to trouble ‘reattaching’ to daughter after nearly losing her to 'horrifying' ...
Fox News· 6 days ago"When my daughter West was 9 months old, she got RSV, which kind of was in the news again a couple...
NanoViricides Has Filed its Quarterly Report
Digital Journal· 3 hours agoSHELTON, CT / ACCESSWIRE / May 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its Quarterly ...
Moderna Says FDA Delaying Decision on RSV Vaccine Approval
Bloomberg· 5 days agoHave a confidential tip for our reporters? US regulators’ decision on whether to approve Moderna...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 5 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall
David Duchovny Had Trouble 'Reattaching' to Daughter After 'Nightmare' RSV Experience: 'We Could...
People via Yahoo News· 7 days agoWhen the actor's daughter West was 9 months old, she stayed in the hospital for a period after...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 2 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine ...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall By Investing.com
Investing.com· 5 days agoModerna (NASDAQ:MRNA) shares are down just over 1% in early Friday trading after the company said...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 5 days agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
Quick takes: Moderna's RSV vaccine, flu-COVID combo vaccines, new polio cases
Center for Infectious Disease Research and Policy· 4 days agoThe FDA has pushed back its review of Moderna's RSV vaccine owing to administrative issues.
